Legal & General Group
HOOK

Legal & General Group’s HOOKIPA Pharma HOOK Stock Holding History

Legal & General Group’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-184
Closed -$4K – 3583
2022
Q1 		$4K Hold
184
– – ﹤0.01% 3518
2021
Q4 		$4K Hold
184
– – ﹤0.01% 3554
2021
Q3 		$11K Hold
184
– – ﹤0.01% 3430
2021
Q2 		$17K Buy
184
+43
+30% +$5.74K ﹤0.01% 3347
2021
Q1 		$19K Sell
141
-12
-8% -$1.45K ﹤0.01% 3144
2020
Q4 		$17K Hold
153
– – ﹤0.01% 3155
2020
Q3 		$15K Sell
153
-48
-24% -$4.89K ﹤0.01% 3076
2020
Q2 		$23K Buy
201
+48
+31% +$4.68K ﹤0.01% 3004
2020
Q1 		$13K Sell
153
-54
-26% -$5.91K ﹤0.01% 3082
2019
Q4 		$25K Buy
+207
New +$17.6K ﹤0.01% 3116

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's HOOK Position: Q2 2022 in Review

Legal & General Group sold out of HOOKIPA Pharma (HOOK) in Q2 2022, closing a stake of 184 shares — an estimated $4K sold.

Legal & General Group first reported a position in HOOK in Q4 2019 and held it in 10 quarters. The position peaked at $25K in Q4 2019. 58 funds tracked by Wall St. Rank hold HOOK as of Q2 2022.

  • Legal & General Group reported no remaining HOOKIPA Pharma position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 184 HOOKIPA Pharma shares in Q2 2022, an estimated $4K.
  • Legal & General Group first reported a position in HOOKIPA Pharma in Q4 2019 and held it in 10 quarters.
  • Legal & General Group's HOOKIPA Pharma position peaked at $25K in Q4 2019.
  • 58 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.